← SynDRA
OTS-167
SynDRA canonical compound SYN0079260 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | MELK |
| Mechanism of action | maternal embryonic leucine zipper kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- MELK INHIBITOR
- maternal embryonic leucine zipper kinase inhibitor
Cross-references
Synonyms
- MELK INHIBITOR
- OTS167
- OTSSP167
- OTSSP-167
- AMX10201
- OTS 167
- OTSSP167 free base
- MELK inhibitor
- Melk inhibitor OTS167
- VY778IXU5T
- 1431697-89-0 (free base)
- 1-(6-(3,5-dichloro-4-hydroxyphenyl)-4-(((1r,4r)-4-((dimethylamino)methyl)cyclohexyl)amino)-1,5-naphthyridin-3-yl)ethanone
- 1-[6-(3,5-Dichloro-4-Hydroxyphenyl)-4-({trans-4-[(Dimethylamino)methyl]cyclohexyl}amino)-1,5-Naphthyridin-3-Yl]ethanone
- 4-[7-acetyl-8-[[4-[(dimethylamino)methyl]cyclohexyl]amino]-1H-1,5-naphthyridin-2-ylidene]-2,6-dichlorocyclohexa-2,5-dien-1-one
- Ethanone, 1-(6-(3,5-dichloro-4-hydroxyphenyl)-4-((trans-4-((dimethylamino)methyl)cyclohexyl)amino)-1,5-naphthyridin-3-yl)-
- 1-(6-(3,5-Dichloro-4-hydroxyphenyl)-4-((trans-4-((dimethylamino)methyl)cyclohexyl)amino)-1,5-naphthyridin-3-yl)ethanone
- UNII-VY778IXU5T
- GTPL8046
- CHEMBL3688339
- CHEMBL3692820
- SCHEMBL16337704
- SCHEMBL16337706
- SCHEMBL16337987
- BDBM60438
- CHEBI:95088
- DTXSID90856134
- BDBM166063
- BDBM166150
- BCP09935
- EX-A2119
- NSC801013
- AKOS025117446
- ZINC101773682
- ZINC205186723
- ZINC252584860
- ZINC575440607
- CS-1147
- NSC-801013
- SB17231
Look up OTS-167 in the interactive SynDRA portal →